Trials Starting With "L"

 

LANCELOT-ACS: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of a Reversible PAR-1 Thrombin Receptor Antagonist in Patients with Acute Coronary Syndrome

      -Trial Overview by Dr. Michelle O'Donoghue (TCT 2010)

 

LAPLACE-TIMI57: LDL-C Assessment with PCSK9 monoclonaL Antibody inhibition Combined with statin thErapy - Thrombolysis In Myocardial Infarction-57

      -LDL-C Assessment with PCSK9 monoclonaL Antibody inhibition Combined with statin thErapy - Thrombolysis In Myocardial Infarction-57 by Dr. Robert Giugliano (AHA 2012)

 

Late Stent Thrombosis and Late Restenosis of DES

      -Overview by Dr. Takeshi Kimura (C3 Complex Intervention Meeting 2011)

LAVENDER: Esomeprazole in the Prevention of Recurrent Peptic Ulcer in East Asian Low-Dose Aspirin Users at Gastroinstestinal Risk

      -Poster by Dr. Shinya Goto (AHA 2012)

LEADERS: Limus Eluted from a Durable vs ERodable Stent Coating

      -Biolimus-Eluting Stent With Biodegradable Polymer Versus Sirolimus-Eluting Stent With Durable Polymer by Dr. Stephan Windecker (ESC 2008)

      -2-Year Clinical Follow-Up by Dr. Volker Klauss (TCT 2009)

 

Left Main PCI: Should Guidelines be Changed? Evaluating the Evidence on the Eve of the New Guidelines Publication

      -Overview by Dr. Issam D. Moussa (C3 Complex Intervention Meeting 2011)

LIFE: Losartan Intervention For Endpoint reduction in hypertension study

      -ACC 2002 Scientific Session Presentation by Dr. Bjorn Dahlof

LIMB: Limbs International Medical Buflomedil Trial

      -ACC 2005 Scientific Session Presentation by Dr. Alain Leizorovicz

LIMIT AMI: Limitation of Myocardial Injury following Thromboylsis in Acute Myocardial Infarction

      -An Angiographic Safety and Efficacy Trial of a Novel Anti-CD18 Therapy in Ccute Myocardial Infarction in Conjunction with Thromboylsis by Dr. Kenneth W. Baran (ESC 2008)

LIPID: The Long-Term Intervention with Pravastatin in Ischemic Disease

      -The Long-Term Intervention with Pravastatin in Ischemic Disease by The LIPID Study Group

Lipid-Altering Efficacy and Safety of Simvastatin 80 mg/day: Long-Term Experience in a Large Group of Patients with Hypercholesterolemia:

      -Lipid-Altering Efficacy and Safety of Simvastatin 80 mg/day: Long-Term Experience in a Large Group of Patients with Hypercholesterolemia by Dr. Leiv Ose

 

Lipid-Modulating Effects of Evacetrapib, a Novel CETP Inhibitor, Administered as Monotherapy or in Combination with the Most Commonly Used Statins:

      -Trial Overview by Dr. Stephen Nicholls (AHA 2011)

LIPSIAbciximab-STEMI: Leipzig Immediate PercutaneouS Coronary Intervention Abciximab I.V. Versus I.C. in ST-Elevation Myocardial Infarction Trial

      -Intracoronary Compared with Intravenous Bolus Abciximab Application in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Coronary Intervention by Dr. Holger Thiele

LONG-DES II: Randomized Comparison of the Efficacy of Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent in the Treatment of Long Native Coronary Lesions

      -Trial Overview by Dr. Seung-Jung Park (TCT 2006)

Long-Term Outcomes in Patients Undergoing Coronary Stenting on Dual Oral Antiplatelet Treatment Requiring Oral Anticoagulant Therapy

      -Long-Term Outcomes in Patients Undergoing Coronary Stenting on Dual Oral Antiplatelet Treatment Requiring Oral Anticoagulant Therapy by Dr. R. Rossini

Long-Term Reduction in Low-Density Lipoprotein Cholesterol: A Mendelian Randomized Controlled Trial of Long-Term Reduction of LDL-C Beginning Early in Life

      -Trial Overview by Dr. Brian A. Ference (ACC 2012)

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs

© 1999-2009 by Clinical Trial Results .org.  None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results.  All such requests should be forwarded to Susan J. Marble at smarble@clinicaltrialresults.org. For further information please see the Policy section. Webmaster